Sign In
Buy BLFS
$27.25
-0.240 (-0.87%)
At Close: Jun 03, 2026
BioLife Solutions, Inc. (BLFS) Reports Q3 Loss, Tops Revenue Estimates
06:51pm, Tuesday, 12'th Nov 2024
BioLife Solutions, Inc. (BLFS) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to loss of $0.67 per share a year ago.
BioLife Solutions Reports Third Quarter 2024 Financial Results
04:05pm, Tuesday, 12'th Nov 2024
Cell Processing revenue grew 6% sequentially to $19.0 million; 43% increase compared to 2023 GAAP gross margin of 51% and non-GAAP adjusted gross margin of 54% GAAP net loss from continuing operat
BioLife Solutions Announces $73 Million Sale of its SciSafe Biostorage Subsidiary
08:05am, Tuesday, 12'th Nov 2024
Strategic divestiture heightens focus on proprietary, higher-margin cell processing products All-cash transaction fortifies balance sheet BOTHELL, Wash. , Nov. 12, 2024 /PRNewswire/ -- BioLife Solut
BioLife Solutions to Report Third Quarter 2024 Financial Results and Business Update on November 12, 2024
04:03pm, Thursday, 31'st Oct 2024
BOTHELL, Wash. , Oct. 31, 2024 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapies ("CGT"
Are Medical Stocks Lagging BioLife Solutions (BLFS) This Year?
10:46am, Monday, 21'st Oct 2024
Here is how BioLife Solutions, Inc. (BLFS) and Eli Lilly (LLY) have performed compared to their sector so far this year.
Here's Why Momentum in BioLife Solutions (BLFS) Should Keep going
09:51am, Monday, 07'th Oct 2024
BioLife Solutions (BLFS) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Are Medical Stocks Lagging BioLife Solutions (BLFS) This Year?
10:46am, Tuesday, 17'th Sep 2024
Here is how BioLife Solutions, Inc. (BLFS) and Sensus Healthcare, Inc. (SRTS) have performed compared to their sector so far this year.
BioLife Is Cleaning Ship
03:51pm, Tuesday, 20'th Aug 2024
BioLife was overextended on acquisitions, leading to margin compression and dilution of shareholder capital. The company has divested from non-core businesses, focusing on preservation media where it
BioLife Solutions, Inc. (BLFS) Q2 2024 Earnings Call Transcript
07:50pm, Friday, 09'th Aug 2024
BioLife Solutions, Inc. (NASDAQ:BLFS ) Q2 2024 Earnings Conference Call August 8, 2024 4:30 PM ET Company Participants Troy Wichterman – Chief Financial Officer Rod de Greef – Chairman and Chief E
BioLife Solutions, Inc. (BLFS) Reports Q2 Loss, Tops Revenue Estimates
06:46pm, Thursday, 08'th Aug 2024
BioLife Solutions, Inc. (BLFS) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to loss of $0.23 per share a year ago.
BioLife Solutions Reports Second Quarter 2024 Financial Results
04:03pm, Thursday, 08'th Aug 2024
Cell Processing revenue increased 11% sequentially to $18.0 million GAAP gross margin of 51% and non-GAAP adjusted gross margin of 52% GAAP net loss from continuing operations of $7.1 million and
BioLife Solutions to Report Second Quarter 2024 Financial Results and Business Update on August 8, 2024
04:03pm, Thursday, 25'th Jul 2024
BOTHELL, Wash. , July 25, 2024 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") an
What Makes BioLife Solutions (BLFS) a Good Fit for 'Trend Investing'
09:52am, Friday, 12'th Jul 2024
BioLife Solutions (BLFS) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
BioLife (BLFS) Progresses in Cell & Gene Therapy With CryoCase
12:21pm, Friday, 31'st May 2024
BioLife's (BLFS) latest product, CryoCase, is compatible with various downstream processing systems, including its own Signata CT-5.
BioLife Solutions Introduces the CellSeal CryoCase™ at International Society for Cell & Gene Therapies (ISCT) Conference in Vancouver
08:04am, Wednesday, 29'th May 2024
New container developed for the needs of cell and gene therapy (CGT) primary packaging to replace cryopreservation bags with a fracture resistant, rigid construction built for both manual use and clos
